Treatment-related adverse events
| AEs . | N = 25 . |
|---|---|
| Any-grade adverse events occurring in ≥2 patients, n (%) | |
| Nausea | 5 (20) |
| Fatigue | 3 (12) |
| Arthralgia | 2 (8) |
| Decreased appetite | 2 (8) |
| Mucosal inflammation | 2 (8) |
| Pruritus | 2 (8) |
| Rash | 2 (8) |
| Grade 3/4 adverse events occurring in ≥1 patient, n (%) | |
| Autoimmune hepatitis (grade 3) | 1 (4) |
| γ-Glutamyltransferase increased (grade 3) | 1 (4) |
| Muscular weakness (grade 3)a | 1 (4) |
| Nausea (grade 3)a | 1 (4) |
| Septic shock (grade 4) | 1 (4) |
| AEs . | N = 25 . |
|---|---|
| Any-grade adverse events occurring in ≥2 patients, n (%) | |
| Nausea | 5 (20) |
| Fatigue | 3 (12) |
| Arthralgia | 2 (8) |
| Decreased appetite | 2 (8) |
| Mucosal inflammation | 2 (8) |
| Pruritus | 2 (8) |
| Rash | 2 (8) |
| Grade 3/4 adverse events occurring in ≥1 patient, n (%) | |
| Autoimmune hepatitis (grade 3) | 1 (4) |
| γ-Glutamyltransferase increased (grade 3) | 1 (4) |
| Muscular weakness (grade 3)a | 1 (4) |
| Nausea (grade 3)a | 1 (4) |
| Septic shock (grade 4) | 1 (4) |
Abbreviation: AE, adverse event.
aOccurred in the same patient.